Clinical Trial Update: Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination [Phase 1]

View source ↗

Summary

A Phase 1 pilot safety study evaluated whether the Protector Cap Jet Injector can prevent cross-contamination. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: PATH | Conditions: Virus Diseases, Hepatitis B | Phase 1 | Status: COMPLETED